Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

17.00
-0.4300-2.47%
Post-market: 17.000.00000.00%19:42 EDT
Volume:164.74K
Turnover:2.80M
Market Cap:2.20B
PE:-23.10
High:17.11
Open:16.98
Low:16.81
Close:17.43
52wk High:21.50
52wk Low:12.66
Shares:129.69M
Float Shares:84.12M
Volume Ratio:0.68
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7359
EPS(LYR):-0.8457
ROE:-18.22%
ROA:-6.16%
PB:3.84
PE(LYR):-20.10

Loading ...

Mesoblast (MESO) Gets a Buy from Piper Sandler

TIPRANKS
·
Apr 10

Mesoblast's Fiscal 2026 Net Revenue Projected to be Up to $120 Million, Jefferies Says

MT Newswires Live
·
Apr 10

Assessing Mesoblast’s Valuation After FDA Clears New Ryoncil Trial In Duchenne Muscular Dystrophy

Simply Wall St.
·
Apr 09

Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation

GlobeNewswire
·
Apr 08

Mesoblast's Duchenne Muscular Dystrophy Treatment Heads for US Registrational Clinical Trial; Shares Up Pre-Bell

MT Newswires Live
·
Apr 08

Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy

TIPRANKS
·
Apr 08

Mesoblast Ltd - FDA Clears Ryoncil Ind for Registration Trial in Dmd

THOMSON REUTERS
·
Apr 08

Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga_recent_news
·
Apr 07

Mesoblast Plans New Share Issue to Raise Capital

TIPRANKS
·
Apr 07

BRIEF-Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M

Reuters
·
Apr 07

Mesoblast reports March quarter Ryoncil sales of $30.3M

TIPRANKS
·
Apr 07

Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

GlobeNewswire
·
Apr 07

Mesoblast Ltd - Ryoncil Net Revenue for Quarter Increases to US$30.3M

THOMSON REUTERS
·
Apr 07

Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside

TIPRANKS
·
Mar 27

Mesoblast CEO Granted Additional Options Following Shareholder Approval

TIPRANKS
·
Mar 20

Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme

TIPRANKS
·
Mar 20

Mesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline

TIPRANKS
·
Mar 18

Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026

TIPRANKS
·
Mar 13

Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

GlobeNewswire
·
Mar 12

Mesoblast hires Regeneron veteran to lead clinical development and medical affairs

TIPRANKS
·
Mar 12